An ICMR study says that plasma therapy is not beneficial to patients with severe COVID-19, but it requires further review to confirm the theory.
However, the published study is yet to be peer-reviewed. The convalescent plasma therapy is also administered in patients with early to moderately severe infection worldwide, but adequately powered, randomized controlled trials are still needed to ascertain its effectiveness and efficacy.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.